Renal function after kidney surgery: "it's tough to make predictions, especially about the future"

Affiliations

¹ Department of Urology, George Washington University Medical School, Washington DC, USA.
² Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Editorial

John M DiBianco et al. Ann Transl Med. 2019 Jul.

. 2019 Jul;7(Suppl 3):S82.

doi: 10.21037/atm.2019.04.01.

¹ Department of Urology, George Washington University Medical School, Washington DC, USA.
² Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Predicting Renal Function Outcomes After Partial and Radical Nephrectomy.
Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Bhindi B, et al. Eur Urol. 2019 May;75(5):766-772. doi: 10.1016/j.eururo.2018.11.021. Epub 2018 Nov 23. Eur Urol. 2019. PMID: 30477983

1. Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67:913-24. 10.1016/j.eururo.2015.01.005 - DOI - PubMed
1. Campbell S, Uzzo RG, Allaf ME, et al. Renal Mass and Localized Renal Cancer: AUA Guideline. J Urol 2017;198:520-9. 10.1016/j.juro.2017.04.100 - DOI - PubMed
1. An JY, Ball MW, Gorin MA, et al. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes. Urology 2017;100:151-7. 10.1016/j.urology.2016.10.047 - DOI - PMC - PubMed
1. Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52. 10.1016/j.eururo.2010.12.013 - DOI - PubMed
1. Tan HJ, Norton EC, Ye Z, et al. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 2012;307:1629-35. 10.1001/jama.2012.475 - DOI - PMC - PubMed